Letters to the Editor

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

Division of Oncology, Skane University Hospital, Lund University, Lund
Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm
Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Medicine Solna, Division of Hematology, Karolinska University Hospital Stockholm
Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet and Karolinska University Hospital, Stockholm
Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Department of Immunology, Genetics and Pathology, Clinical and Experimental Oncology, Uppsala University and Uppsala Akademiska Hospital
Division of Oncology, Skane University Hospital, Lund University, Lund
Haematologica Early view Nov 18, 2021 https://doi.org/10.3324/haematol.2021.279037